• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于阵列的淋巴瘤细胞 DNA 甲基化组分析不能明确区分中枢神经系统原发性淋巴瘤和非中枢神经系统弥漫性大 B 细胞淋巴瘤。

Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.

机构信息

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.

Institute of Human Genetics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

出版信息

Genes Chromosomes Cancer. 2019 Jan;58(1):66-69. doi: 10.1002/gcc.22687. Epub 2018 Nov 29.

DOI:10.1002/gcc.22687
PMID:30284345
Abstract

Primary lymphomas of the central nervous system (PCNSL) are diffuse large B-cell lymphomas (DLBCLs) confined to the central nervous system (CNS). We here performed array-based DNA methylation analyses of 26 PCNSL and 78 DLBCL and validated our findings in an independent dataset. We identified 2847 CpGs differentially methylated between PCNSL and non-CNS-DLBCL. Neither a supervised analysis using these CpGs nor application of 3 CpG classifiers selected for class separation unambiguously separated PCNSL from non-CNS-DLBCL. Remarkably, 6/78 non-CNS-DLBCL consistently segregated with PCNSL, which displayed molecular features typical for PCNSL. Our findings suggest that a subset of non-CNS-DLBCL exists which molecularly resembles PCNSL.

摘要

原发性中枢神经系统淋巴瘤(PCNSL)是局限于中枢神经系统(CNS)的弥漫性大 B 细胞淋巴瘤(DLBCL)。我们在此对 26 例 PCNSL 和 78 例 DLBCL 进行了基于阵列的 DNA 甲基化分析,并在独立数据集进行了验证。我们在 PCNSL 和非 CNS-DLBCL 之间鉴定了 2847 个 CpG 差异甲基化。使用这些 CpG 进行的监督分析或选择用于分类分离的 3 个 CpG 分类器都不能明确地区分 PCNSL 和非 CNS-DLBCL。值得注意的是,6/78 例非 CNS-DLBCL 始终与 PCNSL 一致,PCNSL 表现出典型的 PCNSL 分子特征。我们的研究结果表明,存在一部分非 CNS-DLBCL,其分子特征类似于 PCNSL。

相似文献

1
Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.基于阵列的淋巴瘤细胞 DNA 甲基化组分析不能明确区分中枢神经系统原发性淋巴瘤和非中枢神经系统弥漫性大 B 细胞淋巴瘤。
Genes Chromosomes Cancer. 2019 Jan;58(1):66-69. doi: 10.1002/gcc.22687. Epub 2018 Nov 29.
2
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.甲基化标志物能准确地区分原发性中枢神经系统淋巴瘤(PCNSL)与其他中枢神经系统肿瘤。
Clin Epigenetics. 2021 May 5;13(1):104. doi: 10.1186/s13148-021-01091-9.
3
Array-based DNA methylation profiling of primary lymphomas of the central nervous system.基于阵列的中枢神经系统原发性淋巴瘤的 DNA 甲基化分析。
BMC Cancer. 2009 Dec 21;9:455. doi: 10.1186/1471-2407-9-455.
4
Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.免疫特权部位发生的淋巴瘤:对生物学、诊断和发病机制的认识。
Virchows Arch. 2020 May;476(5):647-665. doi: 10.1007/s00428-019-02698-3. Epub 2019 Dec 20.
5
Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.原发性中枢神经系统弥漫性大B细胞淋巴瘤比外周型同类淋巴瘤具有更差的免疫细胞浸润和预后。
Histopathology. 2015 Nov;67(5):625-35. doi: 10.1111/his.12706. Epub 2015 May 19.
6
Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma.比较原发性中枢神经系统淋巴瘤和非中枢神经系统弥漫性大B细胞淋巴瘤的基因芯片基因表达谱分析
Anticancer Res. 2015 Jun;35(6):3333-40.
7
Primary central nervous system lymphomas associated with chronic inflammation: diagnostic pitfalls of central nervous system lymphomas.原发性中枢神经系统淋巴瘤合并慢性炎症:中枢神经系统淋巴瘤的诊断陷阱。
Brain Tumor Pathol. 2020 Oct;37(4):127-135. doi: 10.1007/s10014-020-00373-z. Epub 2020 Jul 5.
8
Primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤
Arch Pathol Lab Med. 2008 Nov;132(11):1830-4. doi: 10.5858/132.11.1830.
9
Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System.中枢神经系统原发性与继发性弥漫大 B 细胞淋巴瘤的临床病理及分子特征的比较研究。
Anticancer Res. 2024 Jul;44(7):2953-2960. doi: 10.21873/anticanres.17107.
10
MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.原发性中枢神经系统弥漫性大 B 细胞淋巴瘤中 MYC、BCL2 和 BCL6 重排。
Ann Hematol. 2019 Jan;98(1):169-173. doi: 10.1007/s00277-018-3498-z. Epub 2018 Oct 11.

引用本文的文献

1
Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modules.基于机器学习推导的DNA甲基化模块对生发中心来源的B细胞淋巴瘤进行亚组分类。
Leukemia. 2025 Apr;39(4):967-971. doi: 10.1038/s41375-025-02533-6. Epub 2025 Mar 10.
2
Navigating Illumina DNA methylation data: biology versus technical artefacts.解读Illumina DNA甲基化数据:生物学因素与技术假象
NAR Genom Bioinform. 2024 Dec 18;6(4):lqae181. doi: 10.1093/nargab/lqae181. eCollection 2024 Dec.
3
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma.
影像组学特征可定义风险,并与原发性中枢神经系统淋巴瘤中的DNA甲基化属性相关联。
Neurooncol Adv. 2023 Oct 18;5(1):vdad136. doi: 10.1093/noajnl/vdad136. eCollection 2023 Jan-Dec.
4
Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes.Kabuki 综合征患者发生的胚胎性横纹肌肉瘤的分子特征:结合肿瘤易感性综合征的报告和文献复习。
Fam Cancer. 2023 Jan;22(1):103-118. doi: 10.1007/s10689-022-00306-z. Epub 2022 Jul 19.
5
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.一种用于 PNMZL 和 PTFL 的统一假说:具有共同分子特征的形态学变体。
Blood Adv. 2022 Aug 23;6(16):4661-4674. doi: 10.1182/bloodadvances.2022007322.
6
Central Nervous System Lymphoma: Novel Therapies.中枢神经系统淋巴瘤:新型疗法
Curr Treat Options Oncol. 2022 Jan;23(1):117-136. doi: 10.1007/s11864-021-00921-5. Epub 2022 Feb 19.
7
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.甲基化标志物能准确地区分原发性中枢神经系统淋巴瘤(PCNSL)与其他中枢神经系统肿瘤。
Clin Epigenetics. 2021 May 5;13(1):104. doi: 10.1186/s13148-021-01091-9.